Suppression of Class Switch Recombination to IgA by RASA2 and RASA3 through Inhibition of TGF-β Signaling
The Journal of Immunology · 2024
DOI: 10.4049/jimmunol.2400353 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, 2024. Verfasst von Sami Mamand und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Immunoglobulin Class Switching, Immunoglobulin A, Signal Transduction, Transforming Growth Factor beta. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: Canadian Government | CIHR | Institute of Infection and Immunity (III).
Abstract (Originalsprache)
Abs play a pivotal role in adaptive immunity by binding to pathogens and initiating immune responses against infections. Processes such as somatic hypermutation and class switch recombination (CSR) enhance Ab affinity and effector functions. We previously carried out a CRISPR/Cas9 screen in the CH12F3-2 (CH12) lymphoma B cell line to identify novel factors involved in CSR. The screen showed that guide RNAs targeting both Rasa2 and Rasa3 genes were decreased in IgA-negative CH12 B cells, implying that these genes might suppress CSR. Indeed, CSR was increased when either Rasa2 or Rasa3 were knocked out in CH12 cells. Compared to controls, Rasa2−/− and Rasa3−/− CH12 cells had increased expression of activation-induced cytidine deaminase (AID) and Iα transcripts, providing an explanation for the increased CSR. The increased CSR, AID, and Iα expression in Rasa2−/− or Rasa3−/− CH12F3-2 is mediated through TGF-β stimulation. Indeed, we found that deletion of RASA2 or RASA3 promotes a shift from noncanonical to canonical TGF-β signaling through SMAD3. These results show that RASA2 and RASA3 are both novel regulators of TGF-β signaling in B cells, a pathway known to be essential for CSR to IgA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Immunology, University of Toronto, Toronto, Ontario, Canada.
ORCID-Profile: Sami Mamand, Heather Liu, Mohammad Kashem, Alberto Martin
Förderung
- Canadian Government | CIHR | Institute of Infection and Immunity (III)
Zitieren
APA
Mamand, S., Liu, H., Kashem, M., & Martin, A. (2024). Suppression of Class Switch Recombination to IgA by RASA2 and RASA3 through Inhibition of TGF-β Signaling. The Journal of Immunology. https://doi.org/10.4049/jimmunol.2400353
Vancouver
Mamand S, Liu H, Kashem M, Martin A. Suppression of Class Switch Recombination to IgA by RASA2 and RASA3 through Inhibition of TGF-β Signaling. The Journal of Immunology. 2024. doi:10.4049/jimmunol.2400353
BibTeX
@article{Mamand2024,
author = {Mamand, Sami and Liu, Heather and Kashem, Mohammad and Martin, Alberto},
title = {Suppression of Class Switch Recombination to IgA by RASA2 and RASA3 through Inhibition of TGF-β Signaling},
journal = {The Journal of Immunology},
year = {2024},
doi = {10.4049/jimmunol.2400353}
}
EUVIMED